| Depressed* | Non-Depressed | P Value |
---|---|---|---|
Characteristics | (n = 494) | (n = 1447) | Â |
Age, y -- % | Â | Â | 0.002 |
19–49 | 21 | 15 |  |
50–64 | 39 | 34 |  |
65–74 | 20 | 29 |  |
> 74 | 20 | 21 | Â |
Male Sex -- % | 63 | 73 | <0.001 |
Income, Canadian $ -- % | Â | Â | <0.001 |
Low (<$30,000) | 33 | 24 | Â |
Intermediate ($30,000 – $59,999) | 34 | 35 |  |
High (>$59,999) | 33 | 42 | Â |
Coronary Risk Factors -- % | Â | Â | Â |
Diabetes | 29 | 22 | 0.001 |
Hypercholesterolemia | 45 | 39 | 0.02 |
Hypertension | 49 | 46 | 0.33 |
Smoking | 43 | 39 | 0.08 |
Non-cardiac comorbidities -- % | Â | Â | Â |
None | 6 | 9 | <0.001 |
1 | 16 | 23 | Â |
2 | 27 | 23 | Â |
3 or more | 51 | 46 | Â |
Prognostic Indicators -- mean (SD) | Â | Â | Â |
GRACE 6-month prognostic index score⌷ | 11.6 (30.3) | 113.6 (28.5) | 0.22 |
DASI Score§ | 11.2 (8.4) | 19.6 (11.8) | <0.001 |
Processes of Care -- % | Â | Â | Â |
Percutaneous transluminal coronary angiography | 8 | 8 | 0.97 |
Coronary angioplasty bypass grafting | 12 | 10 | 0.28 |
ACE Inhibitor | 63 | 62 | 0.64 |
Beta Blocker | 68 | 70 | 0.44 |
Statin | 55 | 55 | 0.89 |
Nitrate | 37 | 31 | 0.01 |